Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000805928-22-000126
Filing Date
2022-12-15
Accepted
2022-12-15 18:05:49
Documents
3
Period of Report
2022-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167114553299439.html 3  
1 FORM 3 wf-form3_167114553299439.xml 3 1734
2 POA JOSEPH TYNDALL HTM axgn-section16poajtyndal.htm EX-24 4525
3 POA JOSEPH TYNDALL JPEG axgn-section16poajtyndal001.jpg GRAPHIC 248410
  Complete submission text file 0000805928-22-000126.txt   350117
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Issuer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address
TYNDALL JOSEPH A. (Reporting) CIK: 0001955281 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36046 | Film No.: 221465936